PMV Pharma names Samsara BioCapital’s Matt Eckler to board
PMVP•PMV Pharmaceuticals named Matt Eckler, a principal at Samsara BioCapital who leads its public equity strategy, to its board of directors.
1. Board appointment
PMV Pharmaceuticals named Matt Eckler to its board. Eckler is a principal at Samsara BioCapital, where he leads its public equity strategy, and previously held investment roles at ArrowMark Partners, GMT Capital and RBC Capital Markets.
